LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,591,884 | -29.4% | 360,345 | -15.0% | 1.01% | -26.7% |
| Q2 2023 | $30,571,784 | -7.5% | 424,019 | -5.7% | 1.38% | -16.2% |
| Q1 2023 | $33,065,822 | +55.1% | 449,508 | +40.9% | 1.64% | +39.5% |
| Q4 2022 | $21,312,820 | -46.1% | 319,054 | -30.5% | 1.18% | -48.5% |
| Q3 2022 | $39,552,000 | -1.1% | 459,315 | +2.4% | 2.29% | +3.5% |
| Q2 2022 | $40,003,000 | -27.7% | 448,363 | -8.8% | 2.21% | -7.2% |
| Q1 2022 | $55,313,000 | -18.0% | 491,717 | +12.7% | 2.38% | -5.1% |
| Q4 2021 | $67,415,000 | +9.9% | 436,456 | -0.9% | 2.51% | +7.9% |
| Q3 2021 | $61,340,000 | +1.9% | 440,283 | -4.1% | 2.33% | -1.1% |
| Q2 2021 | $60,210,000 | -12.0% | 458,955 | +2.3% | 2.35% | -18.5% |
| Q1 2021 | $68,395,000 | +106.6% | 448,637 | +34.8% | 2.89% | +95.2% |
| Q4 2020 | $33,102,000 | -28.5% | 332,854 | -31.5% | 1.48% | -37.9% |
| Q3 2020 | $46,310,000 | +54.1% | 485,842 | +80.8% | 2.38% | +36.7% |
| Q2 2020 | $30,061,000 | – | 268,761 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |